NASDAQ:SNES SenesTech (SNES) Stock Price, News & Analysis → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free SNES Stock Alerts $0.68 +0.01 (+1.49%) (As of 05/16/2024 ET) Add Compare Share Share Today's Range$0.63▼$0.7250-Day Range$0.64▼$0.9252-Week Range$0.52▼$17.40Volume102,737 shsAverage Volume386,265 shsMarket Capitalization$3.51 millionP/E RatioN/ADividend YieldN/APrice Target$3.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get SenesTech alerts: Email Address SenesTech MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside412.8% Upside$3.50 Price TargetShort InterestBearish7.79% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.02Based on 14 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.66) to ($0.44) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.44 out of 5 stars 3.5 Analyst's Opinion Consensus RatingSenesTech has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageSenesTech has only been the subject of 1 research reports in the past 90 days.Read more about SenesTech's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted7.79% of the float of SenesTech has been sold short.Short Interest Ratio / Days to CoverSenesTech has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in SenesTech has recently increased by 53.57%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSenesTech does not currently pay a dividend.Dividend GrowthSenesTech does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SNES. Previous Next 1.1 News and Social Media Coverage News SentimentSenesTech has a news sentiment score of -0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for SenesTech this week, compared to 2 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, SenesTech insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.32% of the stock of SenesTech is held by insiders.Percentage Held by InstitutionsOnly 5.19% of the stock of SenesTech is held by institutions.Read more about SenesTech's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for SenesTech are expected to grow in the coming year, from ($0.66) to ($0.44) per share.Price to Book Value per Share RatioSenesTech has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about SenesTech's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Gold Safe ExchangeGold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! About SenesTech Stock (NASDAQ:SNES)SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.Read More SNES Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SNES Stock News HeadlinesMay 17 at 3:40 AM | americanbankingnews.comSenesTech (NASDAQ:SNES) Now Covered by Analysts at StockNews.comMay 16 at 6:56 AM | americanbankingnews.comBrokers Set Expectations for SenesTech, Inc.'s Q2 2024 Earnings (NASDAQ:SNES)May 16 at 4:54 AM | americanbankingnews.comSenesTech (NASDAQ:SNES) Rating Reiterated by HC WainwrightMay 15 at 7:14 PM | markets.businessinsider.comBuy Rating Affirmed on SenesTech’s Growth and Strategic ExpansionMay 13, 2024 | finance.yahoo.comSenesTech First Quarter 2024 Earnings: Misses ExpectationsMay 12, 2024 | finance.yahoo.comSenesTech, Inc. (NASDAQ:SNES) Q1 2024 Earnings Call TranscriptMay 11, 2024 | uk.investing.comEarnings call: SenesTech Inc. sees 78% revenue surge in Q1 2024May 10, 2024 | finanznachrichten.deSenesTech, Inc.: SenesTech Announces First Quarter 2024 Financial ResultsMay 9, 2024 | prnewswire.comSenesTech Announces First Quarter 2024 Financial ResultsMay 9, 2024 | americanbankingnews.comSenesTech (NASDAQ:SNES) Receives New Coverage from Analysts at StockNews.comMay 8, 2024 | americanbankingnews.comSenesTech (SNES) to Release Earnings on ThursdayMay 2, 2024 | prnewswire.comSenesTech to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024May 2, 2024 | prnewswire.comSenesTech Launches Evolve™ MouseApril 2, 2024 | prnewswire.comSenesTech to Present at the Emerging Growth Conference on April 3, 2024March 28, 2024 | theglobeandmail.comSenesTech (NASDAQ: SNES) Inks Deal with Wilco Distributing for Pest-Management ProductsMarch 27, 2024 | finance.yahoo.comSenesTech Signs Wilco Distributing for Evolve™ and ContraPest® Distribution in Agriculture and Professional Rodent Pest Management MarketMarch 20, 2024 | theglobeandmail.comSenesTech (NASDAQ: SNES) Closes Multiple Global Distribution DealsMarch 19, 2024 | theglobeandmail.comSenesTech (NASDAQ: SNES) Expanding Global Reach with Innovative ProductsMarch 7, 2024 | theglobeandmail.comSenesTech (NASDAQ: SNES) Announces Participation at Emerging Growth ConferenceMarch 6, 2024 | theglobeandmail.comSenesTech (NASDAQ: SNES) Posts Fiscal Year 2023 Results, Reports Revenue GrowthMarch 5, 2024 | prnewswire.comSenesTech to Present at the Emerging Growth Conference on March 6, 2024February 24, 2024 | finance.yahoo.comSenesTech, Inc. (NASDAQ:SNES) Q4 2023 Earnings Call TranscriptFebruary 24, 2024 | investing.comEarnings call: SenesTech reports solid growth and optimistic outlookFebruary 24, 2024 | theglobeandmail.comSenesTech (NASDAQ: SNES) Continues to Increase Rat Birth Control Product DistributionFebruary 23, 2024 | finance.yahoo.comSenesTech Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagSee More Headlines Receive SNES Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SenesTech and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today5/16/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Agricultural chemicals Sub-IndustryN/A Current SymbolNASDAQ:SNES CUSIPN/A CIK1680378 Webwww.senestech.com Phone(928) 779-4143FaxN/AEmployees25Year FoundedN/APrice Target and Rating Average Stock Price Target$3.50 High Stock Price Target$3.50 Low Stock Price Target$3.50 Potential Upside/Downside+412.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,710,000.00 Net Margins-545.82% Pretax Margin-545.82% Return on Equity-181.46% Return on Assets-146.47% Debt Debt-to-Equity Ratio0.03 Current Ratio6.91 Quick Ratio5.69 Sales & Book Value Annual Sales$1.19 million Price / Sales2.95 Cash FlowN/A Price / Cash FlowN/A Book Value$0.90 per share Price / Book0.76Miscellaneous Outstanding Shares5,140,000Free Float4,871,000Market Cap$3.51 million OptionableNot Optionable Beta0.68 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Joel L. Fruendt (Age 63)CEO, President & Director Comp: $282.85kMr. Thomas C. Chesterman M.B.A. (Age 65)Executive VP, CFO, Treasurer & Secretary Comp: $261.43kRobert BlumInvestor RelationsKey CompetitorsPhio PharmaceuticalsNASDAQ:PHIOKiromic BioPharmaNASDAQ:KRBPSharps TechnologyNASDAQ:STSSENDRA Life SciencesNASDAQ:NDRANovaBay PharmaceuticalsNYSE:NBYView All CompetitorsInstitutional OwnershipMcAdam LLCBought 64,348 shares on 4/23/2024Ownership: 1.252%View All Institutional Transactions SNES Stock Analysis - Frequently Asked Questions Should I buy or sell SenesTech stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SenesTech in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SNES shares. View SNES analyst ratings or view top-rated stocks. What is SenesTech's stock price target for 2024? 1 analysts have issued 1-year target prices for SenesTech's shares. Their SNES share price targets range from $3.50 to $3.50. On average, they predict the company's stock price to reach $3.50 in the next twelve months. This suggests a possible upside of 412.8% from the stock's current price. View analysts price targets for SNES or view top-rated stocks among Wall Street analysts. How have SNES shares performed in 2024? SenesTech's stock was trading at $1.27 on January 1st, 2024. Since then, SNES shares have decreased by 46.3% and is now trading at $0.6825. View the best growth stocks for 2024 here. When is SenesTech's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024. View our SNES earnings forecast. How were SenesTech's earnings last quarter? SenesTech, Inc. (NASDAQ:SNES) posted its quarterly earnings results on Thursday, May, 9th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.34) by $0.02. The firm earned $0.42 million during the quarter, compared to analysts' expectations of $0.43 million. SenesTech had a negative net margin of 545.82% and a negative trailing twelve-month return on equity of 181.46%. During the same period in the prior year, the company posted ($15.85) EPS. When did SenesTech's stock split? Shares of SenesTech reverse split on Friday, November 17th 2023. The 1-12 reverse split was announced on Wednesday, November 15th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, November 16th 2023. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. What other stocks do shareholders of SenesTech own? Based on aggregate information from My MarketBeat watchlists, some companies that other SenesTech investors own include Carrizo Oil & Gas (CRZO), Auris Medical (EARS), Marathon Oil (MRO), Adamis Pharmaceuticals (ADMP), McDermott International (MDR), ZIOPHARM Oncology (ZIOP), Citius Pharmaceuticals (CTXR) and DURECT (DRRX). When did SenesTech IPO? SenesTech (SNES) raised $15 million in an initial public offering on Thursday, December 8th 2016. The company issued 1,900,000 shares at a price of $8.00 per share. Roth Capital Partners served as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager. Who are SenesTech's major shareholders? SenesTech's stock is owned by a variety of retail and institutional investors. Top institutional investors include McAdam LLC (1.25%). View institutional ownership trends. How do I buy shares of SenesTech? Shares of SNES stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SNES) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the Markets348 million Americans lives to END as we know it?The Oxford Club[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SenesTech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
